Advances in targeted therapy for acute myeloid leukemia | Biomarker Research | Full Text

Advances in targeted therapy for acute myeloid leukemia | Biomarker Research | Full Text

Advances in targeted therapy for acute myeloid leukemia

Acute myeloid leukemia (AML) is a clonal malignancy characterized by genetic heterogeneity due to recurrent gene mutations. Treatment with cytotoxic chemotherapy has been the standard of care for more than hal...

Authors:Jifeng Yu, Peter Y. Z. Jiang, Hao Sun, Xia Zhang, Zhongxing Jiang, Yingmei Li and Yongping Song

Citation:Biomarker Research 2020 8:17

Content type:Review

Published on: 20 May 2020

• ViewFull Text
 
• ViewPDF